REMODULIN for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 372 adverse event reports in the FDA FAERS database where REMODULIN was used for Pulmonary arterial hypertension.
Most Reported Side Effects for REMODULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 95 | 13.7% | 93 | 8 |
| Dyspnoea | 79 | 11.4% | 4 | 71 |
| Device related infection | 64 | 9.2% | 1 | 63 |
| Drug dose omission | 42 | 6.0% | 1 | 37 |
| Nausea | 32 | 4.6% | 0 | 25 |
| Headache | 30 | 4.3% | 0 | 18 |
| Diarrhoea | 28 | 4.0% | 1 | 19 |
| Pulmonary arterial hypertension | 28 | 4.0% | 10 | 20 |
| Vomiting | 28 | 4.0% | 1 | 24 |
| Fluid retention | 27 | 3.9% | 1 | 23 |
| Pneumonia | 27 | 3.9% | 1 | 25 |
| Hypotension | 24 | 3.5% | 3 | 20 |
| Fall | 23 | 3.3% | 2 | 16 |
| Infusion site pain | 21 | 3.0% | 0 | 10 |
| Dizziness | 20 | 2.9% | 0 | 15 |
Other Indications for REMODULIN
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)